SCHEMBL4274765

SCHEMBL4274765

Brc1c(OCc2nnn[nH]2)ccc2cc(-c3csc(-c4ccccc4)n3)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 1/20 0.42
CDC25B P30305 1/20 0.42
CDC25C P30307 1/20 0.42
DUSP3 P51452 1/20 0.42
KDM4E B2RXH2 3/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
RAB9A P51151 2/20 0.37
SREBF2 Q12772 2/20 0.37
AR P10275 1/20 0.36
ATP4A P20648 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4265820 0.83 CDC25A (0.53) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL4275471 0.81 CDC25A (0.47) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL4264751 0.79 PTPN1 (0.47) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL4273584 0.79 KDM4E (0.56) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL4267047 0.76 CDC25A (0.51) CDC25ACDC25BCDC25CDUSP3ATP4A
SCHEMBL4268816 0.76 SMPD1 (0.46) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL4672861 0.76 ROCK1 (0.41) KMT2ASMN1; SMN2MEN1MAPTRAB9A
SCHEMBL4672074 0.76 NCEH1 (0.34) KMT2ASMN1; SMN2MEN1MAPTRAB9A
SCHEMBL5335829 0.73 PTPN1 (0.34) KMT2ASMN1; SMN2MEN1ALDH1A1LMNA
SCHEMBL4673581 0.73 NCEH1 (0.37) KMT2ASMN1; SMN2MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090326021-A1 THIAZOLO NAPHTHYL ACIDS WYETH (US) 2009-12-31 US claimed
US-7605172-B2 Thiazolo-naphthyl acids WYETH (US) 2009-10-20 US claimed
US-20060052420-A1 Plasminogen activator inhibitor-1 (PAI-1) modulators; 3-phenyl-2-{[6-(2-phenyl-1,3-thiazol-4-yl)-2-naphthyl]oxy}propanoic acid; thrombosis; cardiovascular disease WYETH (US) 2006-03-09 US claimed
US-20090326021-A1 THIAZOLO NAPHTHYL ACIDS WYETH (US) 2009-12-31 US disclosed
US-7605172-B2 Thiazolo-naphthyl acids WYETH (US) 2009-10-20 US disclosed
EP-1794138-A2 THIAZOLO-NAPHTHYL ACIDS AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Wyeth (US) 2007-06-13 EP disclosed
US-20060052420-A1 Plasminogen activator inhibitor-1 (PAI-1) modulators; 3-phenyl-2-{[6-(2-phenyl-1,3-thiazol-4-yl)-2-naphthyl]oxy}propanoic acid; thrombosis; cardiovascular disease WYETH (US) 2006-03-09 US disclosed
WO-2006023866-A2 THIAZOLO-NAPHTHYL ACIDS AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 WYETH (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326021-A1 THIAZOLO NAPHTHYL ACIDS SERPINE1, SERPINC1, SERPINB1 CDC25A 2791/4885CDC25B 3072/4885CDC25C 3220/4885
US-20060052420-A1 Plasminogen activator inhibitor-1 (PAI-1) modulators; 3-phenyl-2-{[6-(2-phenyl-1,3-thiazol-4-yl)-2-naphthyl]oxy}propanoic acid; thrombosis; cardiovascular disease SERPINE1, PLAT, SERPINC1 CDC25A 2671/4885CDC25B 3732/4885CDC25C 3520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.